Sangamo Therapeutics (SGMOQ) Net Cash Flow (QoQ) (2010 - 2025)
Powered by 
Analysis
Sangamo Therapeutics (SGMOQ) Net Cash Flow (QoQ) (2010 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.28 Bn | 9.43 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.20 Bn | 5.20 Bn | - |
| 3 | Iovance Biotherapeutics | 3.76 Bn | 3.46 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn |
| 5 | uniQure | 3.07 Bn | 3.07 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.67 Bn | 2.67 Bn | - |
| 7 | Precigen | 2.43 Bn | 2.43 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.34 Bn | 1.54 Bn | 251.87 Mn |
| 9 | Vericel | 2.00 Bn | 1.83 Bn | 56.40 Mn |
| 10 | Sangamo Therapeutics | 43.15 Mn | 22.20 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -2.80% |
| Sep 30, 2025 | -189.70% |
| Jun 30, 2025 | 157.91% |
| Mar 31, 2025 | -462.91% |
| Dec 31, 2024 | -57.89% |
| Sep 30, 2024 | 143.20% |
| Jun 30, 2024 | -393.47% |
| Mar 31, 2024 | 173.43% |
| Dec 31, 2023 | -29.66% |
| Sep 30, 2023 | 16.70% |
| Jun 30, 2023 | 48.05% |
| Mar 31, 2023 | -542.64% |
| Dec 31, 2022 | 121.92% |
| Sep 30, 2022 | -767.34% |
| Jun 30, 2022 | 95.44% |
| Mar 31, 2022 | -2,994.10% |
| Dec 31, 2021 | -71.15% |
| Sep 30, 2021 | -84.92% |
| Jun 30, 2021 | 682.49% |
| Mar 31, 2021 | 93.72% |